Literature DB >> 11098044

ESHRE preimplantation genetic diagnosis (PGD) consortium: data collection II (May 2000).

J Geraedts1, A Handyside, J Harper, I Liebaers, K Sermon, C Staessen, A Thornhill, S Viville, L Wilton.   

Abstract

In 1997, the ESHRE PGD Consortium was formed as part of the ESHRE Special Interest Group on Reproductive Genetics, in order to undertake a long-term study of the efficacy and clinical outcome of preimplantation genetic diagnosis (PGD). In December 1999, the first PGD Consortium report was published discussing referrals of 323 couples, 392 PGD cycles and 82 pregnancies and 79 children born. In the second round of data collection, contributing centres were asked to send in data from their PGD activities before January 1997, as well as from 1st October 1998 until 1st May 2000, in order to have as complete as possible an overview of PGD practices in these centres. A further 563 referrals were sent in as well as 926 PGD cycles, and data on 89 pregnancies (including seven pregnancies ongoing from the previous group) and 83 children were collected. This has led to a considerable amount of cumulative data being acquired: over a period of 7 years (the oldest PGD cycle reported dates from 1994), referral data on 886 couples, cycle data on 1318 PGD cycles and data on 163 pregnancies and 162 babies were collected. In all, these data are encouraging: they show first, that the practice of PGD is becoming more and more established, and an increasing number of different applications is emerging; and second, that collecting these data is worthwhile, as they will be a valuable source of information for all those involved, e.g. in counselling patients and interacting with governmental bodies.

Entities:  

Mesh:

Year:  2000        PMID: 11098044     DOI: 10.1093/humrep/15.12.2673

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  Preimplantation genetic diagnosis.

Authors:  F A Flinter
Journal:  BMJ       Date:  2001-04-28

Review 2.  Molecular diagnostics in preimplantation genetic diagnosis.

Authors:  Alan R Thornhill; Karen Snow
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

Review 3.  Preimplantation genetic diagnosis in clinical practice.

Authors:  E Kanavakis; J Traeger-Synodinos
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

4.  Ethical considerations on indications for gender selection in Japan.

Authors:  Takahide Mori; Hirohiko Watanabe
Journal:  J Assist Reprod Genet       Date:  2002-09       Impact factor: 3.412

Review 5.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

6.  Comparison of growth rates of fresh and frozen-thawed embryos according to chromosomal status.

Authors:  Rohini Edirisinghe; Rodney Jemmott; John Allan
Journal:  J Assist Reprod Genet       Date:  2005-08       Impact factor: 3.412

7.  Preimplantation genetic diagnosis for Down syndrome pregnancy.

Authors:  Yu Zhang; Chen-ming Xu; Yi-min Zhu; Min-yue Dong; Yu-li Qian; Fan Jin; He-feng Huang
Journal:  J Zhejiang Univ Sci B       Date:  2007-07       Impact factor: 3.066

8.  ESHRE PGT Consortium data collection XVI-XVIII: cycles from 2013 to 2015.

Authors:  E Coonen; A van Montfoort; F Carvalho; G Kokkali; C Moutou; C Rubio; M De Rycke; V Goossens
Journal:  Hum Reprod Open       Date:  2020-10-03

9.  Incidence of chromosomal mosaicism in morphologically normal nonhuman primate preimplantation embryos.

Authors:  Cathérine Dupont; James Segars; Alan DeCherney; Barry D Bavister; D Randall Armant; Carol A Brenner
Journal:  Fertil Steril       Date:  2009-09-03       Impact factor: 7.329

10.  The status of preimplantation genetic testing in the UK and USA.

Authors:  Rachel Theobald; Sioban SenGupta; Joyce Harper
Journal:  Hum Reprod       Date:  2020-04-28       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.